The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The Sexually Transmitted Diseases (STD) Testing Market By The End Of 2030?
The sexually transmitted diseases (std) testing market has experienced substantial growth in recent years. It is anticipated to increase from $8.78 billion in 2025 to $9.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.5%. This growth during the historic period is attributable to an increasing awareness of sexual health, the expansion of public health screening programs, improvements in laboratory diagnostic capabilities, a rising prevalence of sexually transmitted infections, and broader availability of testing services.
The sexually transmitted diseases (STD) testing market is poised for significant expansion in the upcoming years. It is projected to reach $13.05 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.2%. This anticipated growth during the forecast period is driven by factors such as an escalating demand for confidential testing options, increased investments in molecular diagnostics, the expansion of telehealth-supported testing, a heightened focus on preventive healthcare, and a rise in government initiatives for disease control. Prominent trends expected in this forecast period include the increasing adoption of at-home STD testing kits, a greater utilization of molecular diagnostic technologies, the expanding integration of digital health platforms, the proliferation of rapid point-of-care testing, and an enhanced emphasis on early disease detection.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24695&type=smp
What Primary Drivers Are Shaping The Development Of The Sexually Transmitted Diseases (STD) Testing Market?
The increasing incidence of HIV is expected to drive expansion in the sexually transmitted diseases (STD) testing market over the foreseeable future. HIV, a virus, compromises the immune system by targeting and eliminating vital white blood cells, thereby increasing the body’s susceptibility to infections and illnesses. A surge in HIV diagnoses is attributed to diminishing awareness and prevention initiatives, leading to an increase in individuals participating in high-risk activities like unprotected sex, and a decrease in testing rates, particularly among younger populations. This increase in HIV cases fuels the demand for sexually transmitted disease (STD) testing by elevating public and healthcare consciousness, encouraging more people to pursue thorough testing for early infection detection and to curb further spread. For example, data released in July 2024 by the Joint United Nations Programme on HIV/AIDS (UNAIDS), a Switzerland-based government body, revealed that approximately 1.3 million individuals contracted HIV anew in 2023. This figure is nearly three times higher than the 2025 target of under 370,000 cases. Consequently, the growing prevalence of HIV is set to accelerate the expansion of the sexually transmitted diseases (STD) testing market.
Which Segment Classifications Shape The Sexually Transmitted Diseases (STD) Testing Market?
The sexually transmitted diseases (std) testing market covered in this report is segmented –
1) By Product: Instruments And Services, Consumables, Software
2) By Technology: Immunoassay, Molecular Diagnostics
3) By Sample Type: Blood Samples, Urine Samples, Swabs, Semen Samples, Other Sample Types
4) By Disease Type: Chlamydia, Gonorrhea, Syphilis, HIV Or AIDS, Herpes Simplex Virus (HSV)
5) By End User: Individuals, Healthcare Providers, Diagnostic Laboratories, Govement Health Agencies, NGOs And Community Health Organizations
Subsegments:
1) By Instruments And Services: Diagnostic Instruments, Testing Services
2) By Consumables: Reagents And Kits, Specimen Collection Devices, Slides, Tubes
3) By Software: Laboratory Information Management Systems (LIMS), Electronic Health Records (EHR) Integration Tools, Data Analysis And Reporting Tools, Patient Management Software
What Key Trends Are Influencing The Development Of The Sexually Transmitted Diseases (STD) Testing Market?
Leading companies in the sexually transmitted diseases (STD) testing market are concentrating on developing advanced solutions, such as syphilis testing kits, to expand access to testing for a broader population. Syphilis testing kits are diagnostic instruments utilized to detect the Treponema pallidum bacteria, which causes syphilis, through blood samples or other bodily fluids, enabling timely diagnosis and treatment. For example, in August 2023, iHealth Labs Inc., a US-based medical device company, launched its CheckMeSafe home collection kit for HIV and syphilis testing. The FDA-approved iHealth CheckMeSafe Home Collection kit permits individuals aged 18 and older to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing from the comfort and privacy of their own homes. Users can mail their samples to the lab using a prepaid overnight label and obtain confidential, dependable results in as little as two days. The kit provides highly accurate results, with sensitivity rates of up to 99.9% for HIV and 99.5% for syphilis. All samples are analyzed in a CLIA-certified and CAP-accredited laboratory, ensuring compliance with strict federal and state quality standards through regular inspections.
Which Companies Are Expanding Their Footprint In The Sexually Transmitted Diseases (STD) Testing Market?
Major companies operating in the sexually transmitted diseases (std) testing market are F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton Dickinson And Co., Hologic Inc., QuidelOrtho Corp., Bio-Rad Laboratories Inc., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Sekisui Diagnostics Ltd., Trinity Biotech Plc, Chembio Diagnostics Inc., Operon SA, Jal Medical Pte. Ltd., Anatolia Geneworks, CLIAwaived Inc., Avecon Healthcare Pvt. Ltd., AEHEALTH LIMITED.
Read the full sexually transmitted diseases (std) testing market report here:
How Does The Sexually Transmitted Diseases (STD) Testing Market Perform Across Major Global Regions?
North America was the largest region in the sexually transmitted diseases (STD) testing market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted diseases (std) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Sexually Transmitted Diseases (STD) Testing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24695&type=smp
Browse Through More Reports Similar to the Global Sexually Transmitted Diseases (STD) Testing Market 2026, By The Business Research Company
Liver Diseases Therapeutics Global Market Report
https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report
Rare Diseases Treatment Global Market Report
https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report
Rare Kidney Diseases Global Market Report
https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model